Bile salts and cholestasis

被引:189
作者
Wenniger, Lucas Maillette de Buy [1 ]
Beuers, Ulrich [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Dept Gastroenterol & Hepatol, NL-1012 WX Amsterdam, Netherlands
关键词
Bile acids; Chenodeoxycholate; Primary biliary cirrhosis; Primary sclerosing cholangitis; Ursodeoxycholate; DOSE URSODEOXYCHOLIC ACID; PRIMARY SCLEROSING CHOLANGITIS; PRIMARY BILIARY-CIRRHOSIS; RANDOMIZED CONTROLLED-TRIAL; ENDOPLASMIC-RETICULUM STRESS; PROTEIN-KINASE-C; MITOCHONDRIAL PERMEABILITY TRANSITION; HEPATIC VENOOCCLUSIVE DISEASE; ADENOSYL-L-METHIONINE; VITAMIN-D-RECEPTOR;
D O I
10.1016/j.dld.2010.03.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Bile salts have a crucial role in hepatobiliary and intestinal homeostasis and digestion. Primary bile salts are synthesized by the liver from cholesterol, and may be modified by the intestinal flora to form secondary and tertiary bile salts. Bile salts are efficiently reabsorbed from the intestinal lumen to undergo enterohepatic circulation. In addition to their function as a surfactant involved in the absorption of dietary lipids and fat-soluble vitamins bile salts are potent signaling molecules in both the liver and intestine. Under physiological conditions the bile salt pool is tightly regulated, but the adaptive capacity may fall short under cholestatic conditions. Elevated serum and tissue levels of potentially toxic hydrophobic bile salts during cholestasis may cause mitochondrial damage, apoptosis or necrosis in susceptible cell types. Therapeutic nontoxic bile salts may restore impaired hepatobiliary secretion in cholestatic disorders. The hydrophilic bile salt ursodeoxycholate is today regarded as the effective standard treatment of primary biliary cirrhosis and intrahepatic cholestasis of pregnancy, and is implicated for use in various other cholestatic conditions. Novel therapeutic bile salts that are currently under evaluation may also prove valuable in the treatment of these diseases. (C) 2010 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.
引用
收藏
页码:409 / 418
页数:10
相关论文
共 191 条
[1]
Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats [J].
Alpini, G ;
Glaser, S ;
Baiocchi, L ;
Francis, H ;
Xia, XF ;
LeSage, G .
HEPATOLOGY, 2005, 41 (05) :1037-1045
[3]
HEPATOTOXIC BILE-ACIDS INCREASE CYTOSOLIC CA++ ACTIVITY OF ISOLATED RAT HEPATOCYTES [J].
ANWER, MS ;
ENGELKING, LR ;
NOLAN, K ;
SULLIVAN, D ;
ZIMNIAK, P ;
LESTER, R .
HEPATOLOGY, 1988, 8 (04) :887-891
[4]
Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis? [J].
Asakura, Hitoshi ;
Suzuki, Kenji ;
Kitahora, Tetsuji ;
Morizane, Toshio .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (12) :1794-1801
[5]
Ostα-Ostβ is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver [J].
Ballatori, Nazzareno ;
Fang, Fang ;
Christian, Whitney V. ;
Li, Na ;
Hammond, Christine L. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 295 (01) :G179-G186
[6]
OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids [J].
Ballatori, Nazzareno ;
Li, Na ;
Fang, Fang ;
Boyer, James L. ;
Christian, Whitney V. ;
Hammond, Christine L. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 :2829-2844
[7]
The interaction between bacteria and bile [J].
Begley, M ;
Gahan, CGM ;
Hill, C .
FEMS MICROBIOLOGY REVIEWS, 2005, 29 (04) :625-651
[8]
Benedetti A, 1997, HEPATOLOGY, V26, P9
[9]
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells [J].
Bergamini, A ;
Dini, L ;
Baiocchi, L ;
Cappannoli, L ;
Falasca, L ;
Bolacchi, F ;
Capozzi, M ;
Faggioli, E ;
Nistri, A ;
Salanitro, A ;
Ventura, L ;
Rocchi, G ;
Angelico, M .
HEPATOLOGY, 1997, 25 (04) :927-933
[10]
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis [J].
Bergquist, A ;
Ekbom, A ;
Olsson, R ;
Kornfeldt, D ;
Lööf, L ;
Danielsson, Å ;
Hultcrantz, R ;
Lindgren, S ;
Prytz, H ;
Sandberg-Gertzén, H ;
Almer, S ;
Granath, F ;
Broomé, U .
JOURNAL OF HEPATOLOGY, 2002, 36 (03) :321-327